44
RESEARCH ETHICS IN MEDICAL SCIENCES Ngatidjan Department of Pharmacology and Therapy FoM UGM Medical and Health Research Ethics Committee Faculty of Medicine, Universitas Gadjah Mada RSUP Dr. Sardjito Ngatidjan 1 RESEARCH ETHICS

kuliah etika research

Embed Size (px)

DESCRIPTION

etika riset

Citation preview

  • RESEARCH ETHICS IN MEDICAL SCIENCES

    Ngatidjan

    Department of Pharmacology and Therapy FoM UGM

    Medical and Health Research Ethics Committee

    Faculty of Medicine, Universitas Gadjah Mada RSUP Dr. Sardjito

    Ngatidjan 1 RESEARCH ETHICS

  • Biomedical research :

    pharmaceutics,

    medical devices,

    radiation and imaging,

    surgical procedures,

    medical records,

    biological samples,

    epidemiological,

    social and psychological.

    (is not just basic medical sciences)

    RESEARCH ON MEDICAL SCIENCES

    (Loedin, 2004) Ngatidjan 2 RESEARCH ETHICS

  • BIOMEDICAL RESEARCH :

    Animal, population,

    individually,

    isolated cell, tissue / organ,

    Microorganism, diseases, biological weapon etc.

    Human, population,

    individually,

    isolated cell, tissue / organ.

    have to be clear on ethical aspect why? Ngatidjan 3 RESEARCH ETHICS

  • Research in Biomedical, Clinic and PH

    May involves :

    Animals (healthy or artificially sick),

    Human (healthy or getting sick),

    Isolated cells, tissues, organs or other body components,

    (from animals or human),

    Groups of people or community.

    Ngatidjan 4 RESEARCH ETHICS

  • 5 RESEARCH ETHICS Ngatidjan

    STUDY ON HUMAN

    Experimental study give treatment / intervention

    food, drug, devices, inflict certain condition

    Non-experimental study case control

    cohort

    cross sectional

    survey

    (observation or interview)

    explore things in subject right

  • ETHICAL BASIS

    of studies on human

    Ngatidjan 6 RESEARCH ETHICS

  • 1. Before 19 century

    therapy, empirical based use the most effective.

    2. Since 19 century therapy based on scientific methods scientific based therapy, ethical scandal ethical aspect?

    3. Scandals Tuskegee scandal poorly syphilis patient

    NAZI scandal captured subject of study.

    Nuremberg code (1947),

    Universal declaration of human right (UN 1948),

    Historical background

    Ngatidjan 7 RESEARCH ETHICS

  • 1. Tuskegee scandal a study conducted by Tuskegee Institute (Alabama 1930 1972) in Mason country (82% of residence were black and poor; 36% of them

    were suffering from syphilis)

    the patients did not receive any medical treatment at all although penicillin

    was available (the study was to know the course of the disease).

    the scandal was discovered by a journalist, Jean Heller.

    the study was then stopped by government authority without any trial.

    2. Nazi (Nuremberg) scandal Nuremberg doctor trial on captured people as the subjects.

    the study was discovered in correlation with Nuremberg military tribunal.

    ethical basis Nuremberg code

    History ethics?:

    Ngatidjan 8 RESEARCH ETHICS

  • NUREMBERG CODE 1947

    Voluntary.

    Must have fruitful result.

    Based on the result on animal experimentation.

    As to avoid unnecessary physical or mental suffering.

    Not an life-death harmful result.

    Degree of risk should never exceed the humanitarian.

    Proper and adequate facilities.

    Scientifically qualified researcher.

    Subject may withdrawn freely from the study.

    Experimentation may be stopped anytime if harmful result observed.

    Ngatidjan 9 RESEARCH ETHICS

  • STUDY ON HUMAN

    Experimental study give treatment / intervention food, drug, inflict certain condition

    Non-experimental study case control, cohort, cross sectional,

    survey

    (observation or interview)

    explore subject right

    Ethical Consideration

    Ngatidjan 10 RESEARCH ETHICS

  • ETHICAL BASED OF A RESEARCH

    1. Reasonable ( scientific based),

    2. Managable feasible,

    3. Scientific merit,

    4. Social merit (beneficence),

    5. Competence,

    6. Subject welfare,

    7. Do no harm.

    Ngatidjan 11 RESEARCH ETHICS

  • SIENTIFIC BASED

    1. Reason (background),

    2. Aims of the study,

    3. Design (appropriate design),

    4. Subject criteria (inclusive or exclusive criteria),

    5. Sample size (the reasonable number of subject),

    6. Randomization.

    Ngatidjan 12 RESEARCH ETHICS

  • SIENTIFIC BASED

    7. Data collecting (methods, procedure, etc.).

    8. Data storing.

    9. Data analysis.

    10. Endpoint of the study

    primarily,

    secondary.

    11. The length of time for the study.

    12. Reporting publication.

    Ngatidjan 13 RESEARCH ETHICS

  • ETHICAL BASED OF A RESEARCH

    1. Reasonable ( scientific based),

    2. Managable feasible,

    3. Scientific merit,

    4. Social merit (beneficence),

    5. Competence,

    6. Subject welfare,

    7. Do no harm.

    Ngatidjan 14 RESEARCH ETHICS

  • BASIC PRINCIPLES OF ETHICS

    Respect for person,

    Justice,

    Human right,

    Confidential,

    Beneficence,

    Non malfeasance.

    Ngatidjan 15 RESEARCH ETHICS

  • BASIC PRINCIPLES OF ETHICS

    1. Respect for person Respect for person as human (humanity)

    Respect for autonomy self determination

    Respect for the right

    2. Justice treat everyone in the same manner according to

    morally right and proper, dignity and their right.

    randomization is an example.

    balance of the right and responsibility Ngatidjan 16 RESEARCH ETHICS

  • 3. INFORMED CONSENT

    Information process

    Comprehension

    Volunteerness to join consent

    Ngatidjan 17 RESEARCH ETHICS

  • 3. INFORMED CONSENT

    Informed having information

    an information process must happened

    Consent to give assent or approval

    compliance in or approval of what is done

    or proposed by another

    agreement as to action or opinion

    Volunteerness Ngatidjan 18 RESEARCH ETHICS

  • 3. INFORMED CONSENT

    a set of subject statement consists of :

    the volunteerness to joint in a study

    after having informations of a study, including :

    the procedure of the study

    the risk or any uncomfortable condition may occur

    the advantage of the study

    any alternative therapy can be given

    person can be contacted in an emergency condition

    the possibility of stop joining in the study Ngatidjan 19 RESEARCH ETHICS

  • 3. INFORMED CONSENT

    Sufficient information about the study (research)

    aims of the study procedure benefit risk any alternative (if intervention applied) contact person the possibility of stop in joining participating

    comprehension Ngatidjan 20 RESEARCH ETHICS

  • 3. INFORMED CONSENT

    Volunteerness

    pressure free free from the following things :

    give, reward, present etc. no inducement participations

    status (student from teacher, soldier from commander)

    threat (refuse to joint will get bad mark, will not be serviced)

    fear (fear about future live if refuse to joint into the study)

    consent or willing to participate in the study

    Ngatidjan 21 RESEARCH ETHICS

  • individual consent

    (in developed community, urban area).

    community consent

    (in underdeveloped community, and may

    represented by key person).

    3. INFORMED CONSENT

    Ngatidjan 22 RESEARCH ETHICS

  • 3. INFORMED CONSENT

    Expressed orally

    written

    Implied or tacit (silent, understanding each other)

    normal or constructive consent

    emergency consent

    (consent in an emergency situation)

    Ngatidjan 23 RESEARCH ETHICS

  • 4. CONFIDENTIAL

    Information data, sample / materials have to be kept as a screed.

    selective disclosure of information.

    The use of data or sample as the purposes stated or the aims of the study

    Respondent identity respondent's identity have to be transformed

    to identity number (respondent`s number)

    Ngatidjan 24 RESEARCH ETHICS

  • Client data is confident

    - be ware about data handling and storing.

    is it unlinked or linked information.

    linked information anonymous code.

    written or verbal interview (recorded).

    do not give any chance to trace certain

    (interesting) information

    4. CONFIDENTIAL

    Ngatidjan 25 RESEARCH ETHICS

  • Maximizing benefit, inform to subject about the benefit of the study.

    coordinate with relatives to maximize the benefit.

    accommodate the need of the subject ( patients care).

    participation of relatives (for instance his, her, their family).

    to understand the important of the study.

    Less minimal risk may occured,

    Scientific requirement investigator competence,

    Maintain individual welfare.

    5. BENEFICIAL BENEFICENCE

    Ngatidjan 26 RESEARCH ETHICS

  • Minimizing possible harm.

    - prevent causing harm or doing wrong.

    (does not do thing that is taboo).

    - prevent the occuring of harm to patient and harmful publicity.

    - respect to social mores (for some reason).

    - sensitive to different culture

    do not encounter to existing culture.

    6. DO NO HARM (NONMALFICENCE)

    Ngatidjan 27 RESEARCH ETHICS

  • 6. DO NO HARM (NONMALFICENCE)

    Minimizing possible harm.

    inclusion criteria according to individual patient characteristic (sex, age etc.)

    according to disease characteristic (severity, duration etc.)

    in or out patients

    exclusion criteria according to individual patient characteristic (pregnant etc.)

    according to disease characteristic (severity, duration,

    complicating disease, failure to response to drug etc.)

    Ngatidjan 28 RESEARCH ETHICS

  • 6. DO NO HARM (NONMALFICENCE)

    Blindness masking?

    to avoid bias.

    may use a placebo (negative control treatment) or

    standard treatment (positive control treatment)

    may be as single masking, double masking or triple

    masking etc.

    ethical considerations?

    Ngatidjan 29 RESEARCH ETHICS

  • Placebo involvement?

    Is used when no any standard treatment for the disease.

    Effective if the effect of test drug is much influenced by

    subjective factor (pain, comfort etc.)

    Is appropriate for mild to moderate condition of disease,

    contraindicated for life threatening state of disease.

    no placebo for study of infection therapy etc.

    6. DO NO HARM (NONMALFICENCE)

    Ngatidjan 30 RESEARCH ETHICS

  • ETHICAL ASPECTS OF A PROPOSAL

    Aims of the study

    Design of the study Methods

    Treatments

    Subject recruitment inclusive and exclusive subjects

    vulnerable subjects

    Rescue procedures

    Informed consent

    Confidential respondent identity IN (identity number)

    Ngatidjan 31 RESEARCH ETHICS

  • RESEARCH MISCONDUCT

    Data fabrication,

    Data falsification,

    Plagiarism data stealing,

    or other practices that seriously deviate from those that are commonly accepted within the scientific community for

    proposing, conducting and reporting research.

    author involvement (for anyone who did not involve in a research or without permision),

    there is no any acknowledgement to anyone who actually did most of the research work (i.e. students).

    Ngatidjan 32 RESEARCH ETHICS

  • AGAINST ETHICS IN DOING RESEARCH

    Repeat what other people did on the same topic, etc.

    Stealing the idea,

    Data falsification,

    Submit a proposal which is (the research) had be done,

    Without any informed consent (research on human),

    Put someone name who is never involve in the research,

    Ignore anyone who had ever contributed in the research, etc.

    Ngatidjan 33 RESEARCH ETHICS

  • ETHICAL CLEARANCE

    AND IRB (EC)

    Ngatidjan 34 RESEARCH ETHICS

  • ETHICAL CLEARANCE

    a written statement concerning the ethical property of

    study on human (or animal)

    issued by an IRB (institutional review board)

    in the Faculty of Medicine UGM :

    Komisi Etik Penelitian Kedokteran dan Kesehatan

    (Medical and Health Research Ethics Committee Faculty of

    Medicine Universitas Gadjah Mada RSUP Dr. Sardjito)

    Ngatidjan 35 RESEARCH ETHICS

  • Established by an institution

    which responsible for health and medical sciences

    development faculty / school of medicine

    The roles :

    To review biomedical research for contributing and

    safeguarding the dignity, rights, safety, and well-being of all

    actual or potential research participants

    Institutional Review Board (IRB)

    Ngatidjan 36 RESEARCH ETHICS

  • Carrying out review of proposed research

    before commencement of the research

    Regular evaluation of ethics of on going

    research that received a positive decision

    Institutional Review Board (IRB)

    Ngatidjan 37 RESEARCH ETHICS

  • Membership requirement

    Term of appointment

    Conditions of appointment

    Office(s)

    Quorum requirements

    Independent consultants

    Education of EC member

    Institutional Review Board (IRB)

    Ngatidjan 38 RESEARCH ETHICS

  • Health and medical scientists,

    (At least one of) animal health practitioner,

    (At least one of) law practitioner,

    (At least one of) lay person.

    Chairman,

    Secretary,

    Members.

    Composition of IRB

    Ngatidjan 39 RESEARCH ETHICS

  • Submitting an application

    Reviewing

    Decision making

    Communication decision

    Follow-up

    Documentation & archiving

    IRB and SOP

    Ngatidjan 40 RESEARCH ETHICS

  • Independent and competent

    ethical review is the cornerstone

    for the development of health

    IRB (EC) REVIEW

    Ngatidjan 41 RESEARCH ETHICS

  • Example aspects have to be reviewed :

    Scientific design and conduct of the study,

    Recruitment of research participants,

    Care and protection of research subjects

    Protection of research participant confidentiality

    Informed consent process

    Community consideration

    EELEMENTS OF REVIEWING

    Ngatidjan 42 RESEARCH ETHICS

  • HOW TO GET ETHICAL CLEARANCE

    1. Good written proposal of study on human (or animal)

    Scientific aspect

    Ethical aspect

    2. Research proposal is submitted to IRB

    Review it is communicated to researcher

    Presentation to clarify communication

    Rewrite resubmit re-review communication

    3. Ethical Clearance Ngatidjan 43 RESEARCH ETHICS

  • Ngatidjan 44 RESEARCH ETHICS

    [email protected]